Pahr Therapeutics
Pahr Therapeutics, Inc.
4 Investors
Biotechnology / Pharmaceuticals
BOSTON, MA
Pahr Therapeutics, Inc. is an early-stage or stealth biotechnology company focused on developing therapeutic treatments for diseases. Incorporated in Delaware within the last five years, the company maintains a minimal public profile, suggesting it is likely concentrated on initial research and development phases. Its business model is presumed to be centered on advancing a therapeutic product through clinical trials and regulatory approval, potentially for future commercialization or partnership.
Products & Team
N/A
Therapeutic DevelopmentSeed
There is no publicly available information on any specific products, services, or technology platforms associated with Pahr Therapeutics, Inc.
Value Proposition
The specific diseases or medical problems the company aims to solve have not been publicly disclosed.
Pain Points
N/A
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
BOSTON, MA
Primary headquarters
Funding History
Total Raised:
$4.7M
E
Equity Offering
February 2025
$14.0M
Target
Progress
33%Raised
$4.7M
Target
$14.0M
#000123191925000123